肉瘤的免疫治疗

Q4 Medicine

Nowotwory Pub Date : 2020-12-04 DOI:10.5603/njo.2020.0057

H. Koseła-Paterczyk

{"title":"肉瘤的免疫治疗","authors":"H. Koseła-Paterczyk","doi":"10.5603/njo.2020.0057","DOIUrl":null,"url":null,"abstract":"The introduction of immunotherapy with checkpoint inhibitors into clinical practice has radically changed the treatment and prognosis of patients with cancer. This treatment is also extensively studied in patients diagnosed with advanced sarcomas, where the number of effective therapies is limited. The following review presents the latest reports on the use of immunotherapy in the treatment of patients with sarcomas.","PeriodicalId":39938,"journal":{"name":"Nowotwory","volume":"8 1","pages":"296-302"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Immunotherapy in sarcoma\",\"authors\":\"H. Koseła-Paterczyk\",\"doi\":\"10.5603/njo.2020.0057\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The introduction of immunotherapy with checkpoint inhibitors into clinical practice has radically changed the treatment and prognosis of patients with cancer. This treatment is also extensively studied in patients diagnosed with advanced sarcomas, where the number of effective therapies is limited. The following review presents the latest reports on the use of immunotherapy in the treatment of patients with sarcomas.\",\"PeriodicalId\":39938,\"journal\":{\"name\":\"Nowotwory\",\"volume\":\"8 1\",\"pages\":\"296-302\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nowotwory\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/njo.2020.0057\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nowotwory","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/njo.2020.0057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

检查点抑制剂免疫疗法的引入已经从根本上改变了癌症患者的治疗和预后。这种治疗方法在晚期肉瘤患者中也得到了广泛的研究，在晚期肉瘤患者中，有效治疗方法的数量有限。以下回顾了免疫疗法在肉瘤患者治疗中的最新报道。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Immunotherapy in sarcoma

The introduction of immunotherapy with checkpoint inhibitors into clinical practice has radically changed the treatment and prognosis of patients with cancer. This treatment is also extensively studied in patients diagnosed with advanced sarcomas, where the number of effective therapies is limited. The following review presents the latest reports on the use of immunotherapy in the treatment of patients with sarcomas.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nowotwory Medicine-Oncology

CiteScore

0.90

自引率

0.00%

发文量

期刊介绍： NOWOTWORY Journal of Oncology publishes papers which cover all aspects of oncology but concentrates on clinical studies, both research orientated and treatment orientated, rather than on laboratory studies. Contributions are also welcomed from the fields of epidemiology, tumor pathology, radiobiology and radiation physics.